Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司) is an enterprise in China, with the main office in Suzhou. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The enterprise was incorporated on August 20, 2026. 54 (2025) employees currently work for Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司). During that time, Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司)’s total assets grew by 70.85%.

Headquarters
Room 701, Building B7, Bio-Nanotech Park, No. 218 Xinghu Street, Suzhou Industrial Park, Suzhou Area of the China (Jiangsu) Pilot Free Trade Zone
Suzhou; Jiangsu;

Contact Details: Purchase the Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司) report to view the information.

Basic Information

Total Employees:

Purchase the Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司) report to view the information.

Outstanding Shares:

Purchase the Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司) report to view the information.

Financial Auditors:

Purchase the Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司) report to view the information.

Incorporation Date:

August 20, 2026

Company Performance

Financial values in the chart are available after Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司) report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.

Total Operating Revenue

-67.22%▼

Operating Profit

-8.02%▼

EBITDA

-56.11%▼

Net Profit/Loss for the Period

14.02%▲

Total Assets

70.85%▲

Total Equity

N/A

Return on Equity (ROE)

N/A

Debt / Equity

N/A

Quick Ratio

3.47%▲

Cash Ratio

3.33%▲

Tennor Therapeutics (Suzhou) Ltd. (丹诺医药(苏州)股份有限公司) (China)